• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

氯氮平用于青少年迟发性运动障碍

Clozapine for tardive dyskinesia in adolescents.

作者信息

Levkovitch Y, Kronenberg J, Kayser N, Zvyagelski M, Gaoni B, Gadoth N

机构信息

Shalvata-Mental Health Center, Sackler Faculty of Medicine, Tel Aviv University, Israel.

出版信息

Brain Dev. 1995 May-Jun;17(3):213-5. doi: 10.1016/0387-7604(95)00034-9.

DOI:10.1016/0387-7604(95)00034-9
PMID:7573764
Abstract

Thousands of adolescents use neuroleptic drugs over extended periods of time for a wide range of mental disorders. One of the most severe adverse effects of neuroleptic drugs is tardive dyskinesia (TD), for which no successful treatment is currently available. Clozapine is a known atypical neuroleptic drug with few extrapyramidal side effects. It has been suggested that clozapine may be beneficial for the treatment of tardive dyskinesia in adolescents. However, the efficacy of the drug in adolescents is unknown. This report describes the beneficial effect of clozapine on tardive dyskinesia in two adolescents with schizophrenia.

摘要

数千名青少年长期使用抗精神病药物来治疗各种各样的精神障碍。抗精神病药物最严重的不良反应之一是迟发性运动障碍(TD),目前尚无成功的治疗方法。氯氮平是一种已知的非典型抗精神病药物,几乎没有锥体外系副作用。有人提出氯氮平可能对治疗青少年迟发性运动障碍有益。然而,该药物在青少年中的疗效尚不清楚。本报告描述了氯氮平对两名患有精神分裂症的青少年迟发性运动障碍的有益作用。

相似文献

1
Clozapine for tardive dyskinesia in adolescents.氯氮平用于青少年迟发性运动障碍
Brain Dev. 1995 May-Jun;17(3):213-5. doi: 10.1016/0387-7604(95)00034-9.
2
Clozapine treatment for neuroleptic-induced tardive dyskinesia, parkinsonism, and chronic akathisia in schizophrenic patients.氯氮平治疗精神分裂症患者的抗精神病药物所致迟发性运动障碍、帕金森症及慢性静坐不能。
J Clin Psychiatry. 1997 Jul;58(7):318-22. doi: 10.4088/jcp.v58n0706.
3
Clozapine efficacy in tardive dyskinesia in schizophrenic patients.氯氮平对精神分裂症患者迟发性运动障碍的疗效。
Eur Arch Psychiatry Clin Neurosci. 1998;248(4):209-11. doi: 10.1007/s004060050039.
4
Clozapine treatment of psychosis in patients with tardive dystonia: report of three cases.氯氮平治疗迟发性肌张力障碍患者的精神病:三例报告。
Mov Disord. 1994 May;9(3):321-4. doi: 10.1002/mds.870090308.
5
Neuroleptic reduction and/or cessation and neuroleptics as specific treatments for tardive dyskinesia.减少和/或停用抗精神病药物以及将抗精神病药物作为迟发性运动障碍的特定治疗方法。
Cochrane Database Syst Rev. 2000(2):CD000459. doi: 10.1002/14651858.CD000459.
6
Atypical neuroleptics: clozapine and the benzamides in the prevention and treatment of tardive dyskinesia.
Mod Probl Pharmacopsychiatry. 1983;21:80-6. doi: 10.1159/000408485.
7
New strategies for old problems: tardive dyskinesia (TD). Review and report on severe TD cases treated with clozapine, with 12, 8 and 5 years of video follow-up.
Schizophr Res. 1997 Dec 19;28(2-3):231-46. doi: 10.1016/s0920-9964(97)00130-8.
8
Clozapine and tardive dyskinesia in patients with schizophrenia: A systematic review.氯氮平和精神分裂症患者的迟发性运动障碍:系统评价。
J Psychopharmacol. 2019 Oct;33(10):1187-1198. doi: 10.1177/0269881119862535. Epub 2019 Jul 26.
9
Clozapine in tardive dyskinesia: observations from human and animal model studies.氯氮平治疗迟发性运动障碍:来自人体和动物模型研究的观察结果
J Clin Psychiatry. 1994 Sep;55 Suppl B:102-6.
10
A case of relapsed tardive dyskinesia due to clozapine dose reduction.
Int Clin Psychopharmacol. 2001 Nov;16(6):369-71. doi: 10.1097/00004850-200111000-00009.

引用本文的文献

1
A systematic review on the use of clozapine in treatment of tardive dyskinesia and tardive dystonia in patients with psychiatric disorders.系统评价氯氮平治疗精神障碍患者迟发性运动障碍和迟发性肌张力障碍的疗效。
Psychopharmacology (Berl). 2022 Nov;239(11):3393-3420. doi: 10.1007/s00213-022-06241-2. Epub 2022 Sep 30.
2
[Not Available].[无可用内容]
Paediatr Child Health. 2012 Oct;17(Suppl B):22B-30B.
3
Treatment recommendations for extrapyramidal side effects associated with second-generation antipsychotic use in children and youth.
儿童和青少年使用第二代抗精神病药物相关锥体外系副作用的治疗建议。
Paediatr Child Health. 2011 Nov;16(9):590-8.
4
Clozapine versus typical neuroleptic medication for schizophrenia.氯氮平与传统抗精神病药物治疗精神分裂症的比较。
Cochrane Database Syst Rev. 2009 Jan 21;2009(1):CD000059. doi: 10.1002/14651858.CD000059.pub2.
5
Movement disorders: neurodevelopment and neurobehavioural expression.运动障碍:神经发育与神经行为表现
J Neural Transm (Vienna). 2007;114(4):XXXIII-XLI. doi: 10.1007/s00702-006-0572-9. Epub 2006 Oct 6.
6
Benefit-risk assessment of atypical antipsychotics in the treatment of schizophrenia and comorbid disorders in children and adolescents.非典型抗精神病药物治疗儿童和青少年精神分裂症及共病的获益-风险评估
Drug Saf. 2004;27(14):1135-56. doi: 10.2165/00002018-200427140-00005.
7
Managing antipsychotic-induced acute and tardive dystonia.管理抗精神病药物引起的急性和迟发性肌张力障碍。
Drug Saf. 1998 Jul;19(1):57-72. doi: 10.2165/00002018-199819010-00005.